Abstract
Cytochrome P450 1A1 (CYP1A1) is involved in the production of arachidonic acid-derived vasoactive substance. We hypothesized that CYP1A1 polymorphism might be related to pathological conditions associated with cerebral infarction (CI). We investigated the effect of genetic polymorphism in the 3′-flanking region (T6235C) of CYP1A1 gene in 353 patients with CI and 376 controls. The distributions of T6235C CYP1A1 genotypes in patients with (TT: 36.0%; TC/CT: 64.0%; n = 353) and without CI (TT: 44.7%; TC/CT: 55.3%; n = 376) indicate that the C allele is associated with CI (P = 0.017, odds ratio (O.R.) = 1.44; 95% confidence interval (C. I.) = 1.07–1.94). Furthermore, we examined whether the glutathione S-transferase (GST) gene, which is one of detoxification enzyme, influence the risk of CI. GST M1 null genotype increased the relative risk for the CI in the subjects with the CYP1A1 C allele (P = 0.015, O.R. = 1.47; C. I. = 1.08–2.00). We conclude that T6235C CYP1A1 polymorphism is a risk factor for the development of CI and suggest that GST polymorphism contribute to the odds of CI.
Similar content being viewed by others
References
Abdel-Rahman, S., Z., el-zein, R. A., Anwar, W. A., & Au, W. W. (1996). A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Letters, 107, 229–233.
Albert, R. E., Vanderlaan, M., Burns, F. J., & Nishizumi, M. (1977). Effect of carcinogens on chicken atherosclerosis. Cancer Research, 37(7 Pt 1), 2232–2235.
Awajiri, K., Nakachi, K., Imai, K., Yoshii, A., Shinoda, N., & Watanabe, J. (1990). Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Letters, 263, 131–133.
Bouchardy, C., Wikman, H., Benhamou, S., Hirvonen, A., Dayer, P., & Husgafvel-Pursianinen, K. (1997). CYP1A1 genetic polymorphisms, tobacco smoking and lung cancer risk in a French Caucasian population. Biomarkers, 2, 131–134.
Brockmoller, J., Cascorbi, I., Kerb, R., & Roots, I. (1996). Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Research, 56, 3915–3925.
Cornelis, M. C., El-Sohemy, A., & Campos, H. (2004). Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction. Journal of Medical Genetics, 41(10), 752–762.
Crofts, F., Taioli, E., Trachman, J., Cosma, G. N., Currie, D., & Toniolo, P., et al. (1994). Functional significance of different human CYP1A1 genotypes. Carcinogenesis, 15(12), 2961–2963.
Gaspar, P. A., Hutz, M. H., Salzano, F. M., Hill, K., Hurtado, A. M., Petzl-Erler, M. L., et al. (2002). Polymorphisms of CYP1a1, CYP2e1, GSTM1, GSTT1, and TP53 genes in Amerindians. American Journal of Physical Anthropology, 119(3), 249–256.
Hayashi, S., Watanabe, J., Nakachi, K., & Kawajiri, K. (1991). Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. Journal of Biochemical (Tokyo), 110(3), 407–411.
Hayes, J. D., & Pulford, D. J. (1995). The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Critical Reviews in Biochemistry and Molecular Biology, 30(6), 445–600.
Hirvonen, A., Pursianen, K. H., Karjalainen, A., Anttila, S., & Vainio, H. (1992). Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: Lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiology, Biomarkers & Prevention, 2, 481–485.
Hong, Y. S., Chang, J. H., Kwon, O. J., Ham, Y. A., & Choi, J. H. (1998). Polymorphism of the CYP1A1 and glutathione-S-transferase gene in Korean lung cancer patients. Experimental and Molecular Medicine, 30, 192–198.
Indulski, J. A., & Lutz, W. (2000). Metabolic genotype in relation to individual susceptibility to environmental carcinogens. International Archives of Occupational and Environmental Health, 73(2), 71–85.
Kang, D. (2003). Genetic polymorphisms and cancer susceptibility of breast cancer in Korean women. Journal of Biochemistry and Molecular Biology, 36, 28–34.
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 1215.
Mooney, L. A., Bell, D. A., Santella, R. M., Van Bennekum, A. M., Ottman, R., Paik, M., et al. (1997). Contribution of genetic and nutritional factors to DNA damage in heavy smokers. Carcinogenesis, 18(3), 503–509.
Nebert, D. W., Nelson, D. R., Coon, M. J., Estabrook, R. W., Feyereisen, R., Fujii-Kuriyama, Y., et al. (1991). The P450 superfamily: Update on new sequences, gene mapping, and recommended nomenclature. DNA and Cell Biology, 10, 1–14.
Nerurkar, P. V., Okinaka, L., Aoki, C., Seifried, A., Lum-Jones, A., Wilkens, L. R., et al. (2000). CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals. Cancer Epidemiology, Biomarkers and Prevention, 9(10), 1119–1122.
Nimura, Y., Yokoyama, S., Fujimori, M., Aoki, T., Adachi, T., Nasu, T., et al. (1997). Genotyping of the CYP1A1 and GSTM1 genes in esophageal carcinoma patients with special reference to smoking. Cancer, 80, 852–857.
Penn, A., & Snyder, C. (1988). Arteriosclerotic plaque development is ‘promoted’ by polynuclear aromatic hydrocarbons. Carcinogenesis, 9(12), 2185–2189.
Randerath, E., Mittal, D., & Randerath, K. (1988). Tissue distribution of covalent DNA damage in mice treated dermally with cigarette ‘tar’: Preference for lung and heart DNA. Carcinogenesis, 9(1), 75–80.
Sharma, P. (1996). Genes for ischaemic stroke: Strategies for their detection. Journal de l'hypertension, 14, 277–285.
Shields, P. G., Caporaso, N. E., Falk, R. T., Sugimura, H., Trivers, G. E., Trump, B. F., et al. (1993). Lung cancer, race, and a CYP1A1 genetic polymorphism. Cancer Epidemiology, Biomarkers and Prevention, 2, 481–485.
Solus, J. F., Arietta, B. J., Harris, J. R., Sexton, D. P., Steward, J. Q., McMunn, C., et al. (2004). Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics, 5(7), 895–931.
Um, J. Y., An, N. H., Kim, S. H., Lee, K. M., Kim, Y. S., Jang, H., et al. (2003). Genetic susceptibility to ischemic cerebrovascular disease in Koreans. Journal of Molecular Neuroscience, 20(1), 31–38.
Um, J. Y., Kim, H. M., Han, S. H., Cho, K. H., Moon, B. S., & Hong, S. H. (2006). Glutathione s-transferase gene polymorphism and ischemic cerebrovascular disease. International Journal of Neuroscience, 116(1), 55–65.
Wang, X. L., Greco, M., Sim, A. S., Duarte, N., Wang, J., & Wilcken, D. E. (2002). Effect of CYP1A1 MspI polymorphism on cigarette smoking related coronary artery disease and diabetes. Atherosclerosis, 162, 391–397.
Acknowledgment
This work was supported by the SRC program of KOSEF (R11-2005-014).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moon, KS., Lee, HJ., Hong, SH. et al. CYP1A1 and GSTM1/T1 Genetic Variation in Predicting Risk for Cerebral Infarction. J Mol Neurosci 32, 155–159 (2007). https://doi.org/10.1007/s12031-007-0028-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-007-0028-1